Literature DB >> 20694534

Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.

Di Bei1, Tao Zhang, James B Murowchick, Bi-Botti C Youan.   

Abstract

The purpose of this study was to investigate the physicochemical properties of dacarbazine-loaded cubosomes. The drug-loaded cubosome nanocarriers were prepared by a fragmentation method and then freeze dried. They were then characterized for size, morphology, thermal behavior, and crystallography using dynamic light scattering, transmission electron microscopy (TEM), differential scanning calorimetry (DSC), and powder X-ray diffraction (PXRD), respectively. The drug loading and encapsulation efficiency were determined by UV spectrophotometry. The results showed that the prepared dacarbazine-loaded cubosomes had mean diameters ranging from 86 to 106 nm. In addition to the TEM, the characteristic peaks from PXRD data suggested that the freeze-dried nanoformulations were indeed cubic in nature. DSC and PXRD analysis suggested the 0.06 or 0.28% w/w actual drug loaded inside cubosomes was in the amorphous or molecular state. These physicochemical characteristics would affect the nanoformulation shelf-life, efficacy, and safety.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20694534      PMCID: PMC2974159          DOI: 10.1208/s12249-010-9496-7

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  35 in total

1.  Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer.

Authors:  Idit Amar-Yuli; Ellen Wachtel; Einav Ben Shoshan; Dganit Danino; Abraham Aserin; Nissim Garti
Journal:  Langmuir       Date:  2007-03-01       Impact factor: 3.882

2.  Downscaling drug nanosuspension production: processing aspects and physicochemical characterization.

Authors:  Bernard Van Eerdenbrugh; Bernard Stuyven; Ludo Froyen; Jan Van Humbeeck; Johan A Martens; Patrick Augustijns; Guy Van den Mooter
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

3.  Instantaneous drug delivery of magnetic/thermally sensitive nanospheres by a high-frequency magnetic field.

Authors:  Ting-Yu Liu; Shang-Hsiu Hu; Kun-Ho Liu; Ren-Shiuan Shaiu; Dean-Mo Liu; San-Yuan Chen
Journal:  Langmuir       Date:  2008-12-02       Impact factor: 3.882

4.  Behavior of freezable bound water in the bacterial cellulose produced by Acetobacter xylinum: an approach using thermoporosimetry.

Authors:  Sanae Kaewnopparat; Kamonlawat Sansernluk; Damrongsak Faroongsarng
Journal:  AAPS PharmSciTech       Date:  2008-06-04       Impact factor: 3.246

5.  Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG).

Authors:  K Spieth; R Kaufmann; R Dummer; C Garbe; J C Becker; A Hauschild; W Tilgen; S Ugurel; M Beyeler; E B Bröcker; K C Kaehler; C Pföhler; J Gille; U Leiter; D Schadendorf
Journal:  Ann Oncol       Date:  2008-01-04       Impact factor: 32.976

6.  Indinavir-loaded pH-sensitive microparticles for taste masking: toward extemporaneous pediatric anti-HIV/AIDS liquid formulations with improved patient compliance.

Authors:  Diego A Chiappetta; Angel M Carcaboso; Carlos Bregni; Modesto Rubio; Guillermo Bramuglia; Alejandro Sosnik
Journal:  AAPS PharmSciTech       Date:  2009-01-06       Impact factor: 3.246

7.  Formulation of controlled-release baclofen matrix tablets: influence of some hydrophilic polymers on the release rate and in vitro evaluation.

Authors:  Hamdy Abdelkader; Ossama Youssef Abdalla; Hesham Salem
Journal:  AAPS PharmSciTech       Date:  2007-11-30       Impact factor: 3.246

8.  Investigation of the solid state properties of amoxicillin trihydrate and the effect of powder pH.

Authors:  Alireza Ghassempour; Hasan Rafati; Laleh Adlnasab; Yosef Bashour; Homeira Ebrahimzadeh; Mohammad Erfan
Journal:  AAPS PharmSciTech       Date:  2007-11-09       Impact factor: 3.246

9.  Nanostructured lipid carriers (NLC) in cosmetic dermal products.

Authors:  R H Müller; R D Petersen; A Hommoss; J Pardeike
Journal:  Adv Drug Deliv Rev       Date:  2007-05-17       Impact factor: 15.470

10.  Self-assembly in monoelaidin aqueous dispersions: direct vesicles to cubosomes transition.

Authors:  Anan Yaghmur; Peter Laggner; Mats Almgren; Michael Rappolt
Journal:  PLoS One       Date:  2008-11-18       Impact factor: 3.240

View more
  7 in total

1.  Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier.

Authors:  Musallam Almoussalam; Huijun Zhu
Journal:  J Vis Exp       Date:  2016-04-26       Impact factor: 1.355

2.  Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes.

Authors:  Vijay Prajapati; Aakanchha Jain; Richa Jain; Sanjeev Sahu; Dharm Veer Kohli
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

Review 3.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

4.  Ion exchange column technique as a novel method for evaluating the release of docetaxel from different lipid nanoparticles.

Authors:  Mohamed Dawoud; Randa Abdou
Journal:  Drug Deliv Transl Res       Date:  2021-03-25       Impact factor: 4.617

Review 5.  Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review.

Authors:  Roberta Balansin Rigon; Márcia Helena Oyafuso; Andressa Terumi Fujimura; Maíra Lima Gonçalez; Alice Haddad do Prado; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

6.  Potential combination topical therapy of anal fissure: development, evaluation, and clinical study†.

Authors:  Amgad E Salem; Elham A Mohamed; Hosam M Elghadban; Galal M Abdelghani
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

7.  In vitro and in vivo evaluation of cubosomes containing 5-fluorouracil for liver targeting.

Authors:  Mohamed Nasr; Mohamed K Ghorab; Ahmed Abdelazem
Journal:  Acta Pharm Sin B       Date:  2014-12-29       Impact factor: 11.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.